Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Sep, 2007 | Pubmed ID: 17785729